Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
32232 | 111 | 27.3 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
701 | 12232 | RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | UNIT OTOLARYNGOL HEAD NECK SURG | Address | 2 | 28% | 5% | 5 |
2 | E48 | Author keyword | 1 | 50% | 2% | 2 |
3 | BIOMED RADIAT | Address | 1 | 50% | 1% | 1 |
4 | HUMAN ANTI MOUSE ANTIBODY RESPONSE | Author keyword | 1 | 50% | 1% | 1 |
5 | SQM1 | Author keyword | 1 | 50% | 1% | 1 |
6 | SYNTHETIC ANTIBODY FRAGMENT | Author keyword | 1 | 50% | 1% | 1 |
7 | ANTIBODY BASED THERAPY | Author keyword | 0 | 13% | 2% | 2 |
8 | RADIOIMMUNODIAGNOSIS | Author keyword | 0 | 13% | 2% | 2 |
9 | CARCINOMA ORAL | Author keyword | 0 | 17% | 1% | 1 |
10 | APAAP | Author keyword | 0 | 13% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | E48 | 1 | 50% | 2% | 2 | Search E48 | Search E48 |
2 | HUMAN ANTI MOUSE ANTIBODY RESPONSE | 1 | 50% | 1% | 1 | Search HUMAN+ANTI+MOUSE+ANTIBODY+RESPONSE | Search HUMAN+ANTI+MOUSE+ANTIBODY+RESPONSE |
3 | SQM1 | 1 | 50% | 1% | 1 | Search SQM1 | Search SQM1 |
4 | SYNTHETIC ANTIBODY FRAGMENT | 1 | 50% | 1% | 1 | Search SYNTHETIC+ANTIBODY+FRAGMENT | Search SYNTHETIC+ANTIBODY+FRAGMENT |
5 | ANTIBODY BASED THERAPY | 0 | 13% | 2% | 2 | Search ANTIBODY+BASED+THERAPY | Search ANTIBODY+BASED+THERAPY |
6 | RADIOIMMUNODIAGNOSIS | 0 | 13% | 2% | 2 | Search RADIOIMMUNODIAGNOSIS | Search RADIOIMMUNODIAGNOSIS |
7 | CARCINOMA ORAL | 0 | 17% | 1% | 1 | Search CARCINOMA++ORAL | Search CARCINOMA++ORAL |
8 | APAAP | 0 | 13% | 1% | 1 | Search APAAP | Search APAAP |
9 | CD44 V6 | 0 | 13% | 1% | 1 | Search CD44+V6 | Search CD44+V6 |
10 | TUMOUR UPTAKE | 0 | 11% | 1% | 1 | Search TUMOUR+UPTAKE | Search TUMOUR+UPTAKE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | E48 IGG | 12 | 86% | 5% | 6 |
2 | ANTIBODY E48 IGG | 4 | 75% | 3% | 3 |
3 | MONOCLONAL ANTIBODY U36 | 3 | 42% | 5% | 5 |
4 | U36 | 2 | 40% | 4% | 4 |
5 | BIWA 4 BIVATUZUMAB | 1 | 33% | 2% | 2 |
6 | E48 | 1 | 33% | 2% | 2 |
7 | TUMOR DIAGNOSIS | 1 | 15% | 5% | 5 |
8 | SQM1 | 1 | 50% | 1% | 1 |
9 | PHASE I THERAPY | 1 | 22% | 2% | 2 |
10 | DISSECTION SPECIMENS | 0 | 17% | 2% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
TARGETED RADIONUCLIDE THERAPY IN HEAD AND NECK CANCER | 2010 | 4 | 113 | 20% |
CURRENT PERSPECTIVES IN THE USE OF MONOCLONAL-ANTIBODIES FOR DETECTION AND TREATMENT OF HEAD AND NECK TUMORS | 1994 | 11 | 25 | 44% |
Radioimmunodetection and radioimmunotherapy of head and neck cancer | 2004 | 13 | 81 | 20% |
THE FEASIBILITY OF RADIOIMMUNOTHERAPY OF HEAD AND NECK-CANCER | 1994 | 5 | 34 | 38% |
NEW APPROACH TO THE EVALUATION OF THE RELATIONSHIP BETWEEN HUMORAL AND CELL-MEDIATED-IMMUNITY IN INFECTIOUS-DISEASES | 1984 | 2 | 2 | 50% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNIT OTOLARYNGOL HEAD NECK SURG | 2 | 28% | 4.5% | 5 |
2 | BIOMED RADIAT | 1 | 50% | 0.9% | 1 |
3 | MEDCLIN MAXILLO IAL SURG | 0 | 100% | 0.9% | 1 |
4 | PATHOL TRANSLAT ONCOL | 0 | 100% | 0.9% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000242332 | SMALL CELL LUNG CANCER CELL LINE//SMALL CELL LUNG CANCER CELL LINES//DRUG SCREENING ASSAY |
2 | 0.0000193498 | ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS//RADIOIMMUNOGUIDED SURGERY//IMMUNOSCINTIGRAPHY |
3 | 0.0000140096 | TC 99M V DMSA//BIOPHYS RADIOPHARMACEUT//TC 99M VDMSA |
4 | 0.0000139124 | EGF DEXTRAN//ANTIBODY BINDING PARAMETERS//BIOMED RADIAT SCI |
5 | 0.0000138162 | MAL DE MELEDA//TEX101//SLURP 1 |
6 | 0.0000137785 | VIBRIOCIDAL ANTIBODIES//ANAL CONTROLE QUALITE//FROZEN CHIPS |
7 | 0.0000131097 | IMMUNE SUPPRESSOR CELLS//IRX 2//SERV 151Z2 |
8 | 0.0000122641 | LARYNX CT//LARYNX NEOPLASMS//TONGUE NEOPLASMS |
9 | 0.0000114705 | CD44//CD44V6//CD44 ISOFORMS |
10 | 0.0000112028 | EP CAM//TROP2//EDRECOLOMAB |